ProCE Banner Activity

Slides: Expert Insight Key Data From ASCO 2023 Informing Treatment for Endometrial, Cervical, and Ovarian Cancers

Conference Coverage
Slideset

Download these slides from Kathleen Moore, MD, and Nicoleta Colombo, MD, PhD, with key data for gynecologic cancers presented at the 2023 ASCO Annual Meeting, including practice updated results for immunotherapy in cervical cancer, data for novel immunotherapy-based combination in ovarian, and key results from combination immunotherapy plus chemotherapy combination as frontline treatment for advanced endometrial cancer.

Released: June 13, 2023

Share

Provided by

Provided by Clinical Care Options LLC

ProCE Banner

Supporters

This educational activity is supported by educational grants from AstraZeneca, GlaxoSmithKline, Merck Sharp & Dohme Corp, Novocure, Genmab and Seagen.

AstraZeneca

Genmab

GlaxoSmithKline

Merck Sharp & Dohme Corp.

Novocure

Seagen